How should the GHK-Cu injection evidence be interpreted?
The page previously presented a specific injection dose, weekly schedule, cycle length, reconstitution recipe, and injection technique as practical protocols. The cited human research does not establish those instructions. The controlled human evidence cited here concerns topical products; it cannot validate an injectable dose or schedule.
What human GHK-Cu studies actually tested
| Evidence | Route and question | What it can establish | What it cannot establish |
|---|---|---|---|
| 2018 review of GHK-Cu research | Reviews gene-expression, laboratory, animal, and limited topical human research. | Explains proposed biology and summarizes prior research. | It is not a controlled trial of injected GHK-Cu and does not establish a human injection protocol. |
| Topical photodamaged-skin study | A topical copper-peptide complex was studied for facial skin outcomes. | Evidence about that topical formulation and its studied use. | It does not establish injectable effectiveness, dose, preparation, or frequency. |
| Copper peptide hair-follicle study | Experimental work on AHK-Cu, a different copper peptide. | Findings for that compound and experimental model. | It cannot be treated as a human GHK-Cu injection result. |
Is there a validated GHK-Cu injection dose or reconstitution recipe?
The sources cited on this page do not establish a human injectable GHK-Cu dose, frequency, cycle, injection site, reconstitution volume, diluent, storage period, or stability rule. A concentration table can show arithmetic for a hypothetical vial, but arithmetic is not evidence that the resulting product or amount is appropriate for injection. The former dose table and step-by-step preparation and injection instructions have been removed because the cited studies do not support them.
From the FormBlends catalog
GHK-Cu (Copper Peptide)
A copper peptide studied for skin and tissue support · From $179/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.
View GHK-Cu (Copper Peptide) →Why lab mechanisms do not answer an injection question
Cell and animal findings about collagen signaling, gene expression, or wound models can help researchers form hypotheses. They do not show that an injected product improves skin, hair, or healing in people. A human result depends on the tested compound, formulation, route, population, comparator, and measured outcome.
Evidence summary
- Topical copper-peptide findings are specific to the tested topical products and outcomes.
- Mechanistic and animal studies do not establish an injectable human benefit.
- The sources reviewed here do not provide a validated human GHK-Cu injection dose or preparation protocol.
Sources
- Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987.
- Miller TR, Wagner JD, Baack BR, Eisbach KJ. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. Arch Facial Plast Surg. 2006;8(4):252-259. doi:10.1001/archfaci.8.4.252.
- Pyo HK, Yoo HG, Won CH, et al. The effect of tripeptide-copper complex on human hair growth in vitro. Arch Pharm Res. 2007;30(7):834-839. The study tested AHK-Cu in cultured human dermal papilla cells and ex vivo human hair follicles.
Related peptide guides
Ready when you are
GHK-Cu (Copper Peptide)
A copper peptide studied for skin and tissue support · From $179/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.
View GHK-Cu (Copper Peptide) →